Home > Faculty > University of Minnesota Medical Center > van Burik, Jo-Anne
van Burik, Jo-Anne
 Jo-Anne van Burik, M.D. is an Assistant Professor of Medicine and joined the faculty in January of 1999. She received both her B.A. and M.D. from Case Western Reserve University and completed a residency in Medicine at Vanderbilt University Medical Center. Her fellowship in Infectious Diseases and several years of junior faculty service were at the University of Washington with the Fred Hutchinson Cancer Research Center. Of note, Dr. van Buriks primary area of interest is connecting diagnostic and treatment research from the laboratory to the bedside for transplant patients. She has worked on developing novel methods for the diagnosis of complicated fungal infections in the immunocompromised host. Currently, Dr. van Burik is lead investigator at the University of Minnesota for multiple clinical trials on bacterial, viral, and fungal agents for transplant patients.
Selected Publications:
Van Burik J-A, Lawatsch EJ, DeFor TE, Weisdorf DJ. (2001) Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients. Biology of Blood and Marrow Transplantation 7:674-679.
Toor AA, van Burik J-A, Weisdorf DJ. (2001) Infections during mobilizing chemotherapy and following autologous stem cell transplantation. Bone Marrow Transplantation 28:1129-1134.
Bowden R, Chandrasekar P, White MH, Li X, Pietrelli L, Gurwith M, van Burik J-A, Laverdiere M, Safrin S, Wingard JR. (2002) A Double-Blind, Randomized, Controlled Trial of Amphotericin B Colloidal Dispersion versus Amphotericin B for Treatment of Invasive Aspergillosis in Immunocompromised Patients. Clinical Infectious Disease 35(4):359-66.
Burns LJ, Miller W, Kandaswamy C, DeFor TE, MacMillan ML, van Burik J-A, Weisdorf DJ. (2002) Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation. Bone Marrow Transplantation 30:945-51.
Holman CJ, van Burik J-A, Hinrichs SH, Balfour HH. (2003) Specific detection of human polyomavirus in urine samples of immunocompromised patients. Clinical and Diagnostic Laboratory Immunology 10(1):66-69.
Lephart PR, Ferrieri P, van Burik J-A, (2003, in press) Reservoir of Candida albicans infection in a vascular bypass graft demonstrates a stable karyotype over six months. Medical Mycology.
Van Burik J-A, Ratanatharathorn V, Stepan DE, Miller CB, Lipton J, Vesole DH, Bunin N, Wall D, Lee JM, Walsh TJ. (2003, submitted) Micafungin versus fluconazole for prophylaxis of invasive fungal infections during neutropenia in patients undergoing a hematopoietic stem cell transplant. Clinical Infectious Diseases.
Van Burik J-A, Weisdorf DJ. (1999) Chapter 303: Infections in bone marrow transplant recipients. In Mandell GL, Bennett JE, Dolin R (eds.) Principles and Practice of Infectious Diseases, 5th edition, 3136-3147. Churchill Livingstone.
(2004, in press) Chapter 303: Infections in hematopoietic stem cell transplant recipients. In Mandell GL, Bennett JE, Dolin R (eds.) Principles and Practice of Infectious Diseases, 6th edition. Elsevier Science.
Van Burik J-A, Mycotic infections in the compromised host.
Chapter XXXVIII (2002) In Dale DC (ed.), WebMDb Scientific Americanb Medicine Section 7, Infectious Disease. Available online: www.samed.com.
Chapter 38 (2003) In Dale DC (ed.), WebMDb Infectious Diseases: The clinicians guide to diagnosis, treatment, and prevention, 628-650. WebMD Inc.
Van Burik J-A, Freifeld AG. (2003, in press) Chapter 47: Infections in the severely immunocompromised patient. In Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE (ed.), Clinical Oncology, 3rd edition. Elsevier Science.
|
Return to: Department of Medicine : Medical School : Academic Health Center : myU : U of M Home
